CIE-10

CIE-10-código D46

You are here: Inicio > CIE-10 > C00-D49 > D37-D48

- CIE-10
Clasificación Internacional de Enfermedades
- C00-D49
Tumores [neoplasias]
- D37-D48
Tumores [neoplasias] de comportamiento incierto o desconocido

D46

Síndromes mielodisplásicos

CIE-10 Сódigo D46 para Síndromes mielodisplásicos

Incluye: Tipos morfológicos clasificables en M998 con código de comportamiento /1

D46.0
Anemia refractaria sin sideroblastos, así descrita
D46.1
Anemia refractaria con sideroblastos
D46.2
Anemia refractaria con exceso de blastos
D46.3
Anemia refractaria con exceso de blastos con transformación
D46.4
Anemia refractaria, sin otra especificación
D46.7
Otros síndromes mielodisplásicos
D46.9
Síndrome mielodisplásico, sin otra especificación
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us